|
⚲
|
| Keyboard |
| Wein Matthew
✚
|
|
|---|---|
| CIK # | 0002009713 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002009713] | |
| 4 | [0002009713] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Metagenomi Therapeutics Inc | |
| Wein Matthew |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2026-03-05 | Sell | 482 | $1.60 | 771 |
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2025-12-05 | Sell | 199 | $1.77 | 352 |
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2025-12-01 | Grant | 96,000 | $1.60 | 153,600 |
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2025-09-05 | Sell | 199 | $1.81 | 360 |
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2025-06-06 | Sell | 199 | $1.75 | 348 |
|
Metagenomi Therapeutics Inc MGX
Stock Option (Right to Buy) · derivative
|
2025-04-01 | Grant | 22,725 | $0.00 | |
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2025-04-01 | Grant | 3,775 | $0.00 | |
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2025-04-01 | Grant | 3,650 | $0.00 | |
|
Metagenomi Therapeutics Inc MGX
Stock Option (Right to Buy) · derivative
|
2025-04-01 | Grant | 21,875 | $0.00 | |
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2025-03-05 | Sell | 930 | $1.87 | 1,739 |
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2024-04-01 | Grant | 10,397 | $0.00 | |
|
Metagenomi Therapeutics Inc MGX
Stock Option (Right to Buy) · derivative
|
2024-04-01 | Grant | 43,717 | $0.00 |